Medical costs and vasculometabolic comorbidities among patients with bipolar disorder in Taiwan - A population-based and matched-control study
Resource
J. Affect. Disord., 141(2-3), 449-456
Journal
J. Affect. Disord.
Journal Volume
141
Journal Issue
2-3
Pages
449-456
Date Issued
2012
Date
2012
Author(s)
Abstract
Background: Bipolar disorder (BD) is a costly disease with a high rate of vasculometabolic comorbidities. The aims of this study were to explore the 1-year treatment cost, including total medical and non-psychiatric services, and the prevalence of vasculometabolic comorbidities in individuals with BD.
Methods: A nationwide population-based dataset, covering the years 2006 and 2007, was obtained from the Taiwan National Health Insurance claims database. The study sample comprised patients discharged from hospitals between 1 January 2006 and 31 December 2007. Annual non-psychiatric and total medical costs and vasculometabolic comorbidities were examined. Generalized linear models were used to examine the medical costs, and conditional logistic regression analyses were carried out to test the prevalence of vasculometabolic comorbidities in people with BD and to compare this with that found in matched controls.
Results: The total medical cost was 11-fold higher (New Taiwan [NT] $227,040 vs. NT$20,461), and the non-psychiatric medical cost was 1.7-fold higher (NT$33,173 vs. NT$19,406) with regard to the individuals with BD vs. the matched controls. The prevalence of vasculometabolic comorbidities was significantly higher in the individuals with BD than in the controls (ratio ranging from 1.86 to 4.06).
Conclusions: Both the non-psychiatric healthcare utilization and the prevalence of vasculometabolic comorbidities are higher with regard to individuals with BD vs. their matched controls. Therefore, treatment of BD should integrate medical and psychiatric care to decrease the impact of medical comorbidities, which may also decrease the overall medical cost. (C) 2012 Elsevier B. V. All rights reserved.
Subjects
Bipolar disorder
Non-psychiatric medical cost
Total medical cost
Vasculometabolic comorbidity
SDGs
Other Subjects
adult; article; bipolar disorder; cerebrovascular accident; clinical examination; cohort analysis; comorbidity; controlled study; diabetes mellitus; disease association; essential hypertension; female; health care cost; health care utilization; health insurance; heart disease; hospital discharge; hospitalization; human; hypertension; hypertriglyceridemia; inborn error of metabolism; major clinical study; male; medical service; mental health service; metabolic disorder; multicenter study; population based case control study; prevalence; priority journal; risk factor; Taiwan; vascular disease; vasculometabolic disease; Adult; Bipolar Disorder; Case-Control Studies; Comorbidity; Costs and Cost Analysis; Diabetes Mellitus; Female; Health Care Costs; Heart Diseases; Humans; Hypertension; Lipid Metabolism Disorders; Male; Middle Aged; Prevalence; Retrospective Studies; Socioeconomic Factors; Stroke; Taiwan; Urbanization; Young Adult
File(s)![Thumbnail Image]()
Loading...
Name
index.html
Size
23.17 KB
Format
HTML
Checksum
(MD5):d6a80488f7f3fb4af325213508edcdad